Insider Shareholders with Direct Ownership of Eye Point Pharmaceuticals, Inc. (EYPT)
This section provides a comprehensive overview of the insiders with direct ownership of Eye Point Pharmaceuticals, Inc. (EYPT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
EyePoint Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Nancy Lurker
Executive Vice Chair |
224,600 | 177,667 | 135,441 $1.18 Million | 16 |
Jan 24, 2024
Reduced 18.11%
|
|
Therapeutics Ocumension
Director |
0 | 2,910,500 | 100,221 $871,922 | 3 |
Jan 11, 2024
Reduced 95.02%
|
|
Dario A. Paggiarino
Chief Medical Officer |
223,192 | 165,022 | 67,080 $583,596 | 30 |
Mar 30, 2024
Reduced 9.57%
|
|
Jay S. Duker
President and CEO |
64,951 | 41,188 | 51,920 $451,703 | 11 |
Feb 09, 2024
Reduced 2.73%
|
|
George Elston
Chief Financial Officer |
49,351 | 13,451 | 47,480 $413,075 | 9 |
May 25, 2024
Reduced 7.1%
|
|
David Scott Jones
SVP & Chief Commercial Officer |
121,587 | 88,256 | 44,916 $390,769 | 24 |
Feb 09, 2024
Reduced 3.65%
|
|
Michael Craig Pine
Chief Corp Dev.&Strat. Officer |
61,285 | 50,966 | 13,662 $118,859 | 5 |
Jan 06, 2024
Reduced 30.4%
|
| 7,400 | 0 | 11,400 $99,179 | 3 |
Feb 09, 2023
Added 20.83%
|
|
| 8,150 | 0 | 8,150 $70,905 | 3 |
Feb 09, 2023
Added 28.51%
|
|
| 4,400 | 0 | 8,016 $69,739 | 2 |
Jun 22, 2021
Added 23.77%
|
|
| 7,400 | 0 | 7,400 $64,379 | 3 |
Feb 09, 2023
Added 28.85%
|
|
| 4,000 | 0 | 4,000 $34,800 | 2 |
Jun 23, 2024
Added 33.33%
|
|
| 26,950 | 23,250 | 3,700 $32,189 | 7 |
Jun 03, 2024
Reduced 75.86%
|
|
| 2,000 | 0 | 2,000 $17,400 | 1 |
Jul 11, 2023
Added 50.0%
|
|